LACK OF ACIPIMOX DIGOXIN INTERACTION IN PATIENT VOLUNTEERS

被引:0
|
作者
CHIJIOKE, CP [1 ]
PEARSON, RM [1 ]
BENEDETTI, S [1 ]
机构
[1] ST BARTHOLOMEWS HOSP, DEPT CLIN PHARMACOL, LONDON EC1A 7BE, ENGLAND
关键词
D O I
10.1177/096032719201100509
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
1 A study was carried out to find out if digoxin and acipimox interact. 2 Six elderly patients on digoxin were each given acipimox 150 mg three daily for a week, after informed consent. Digoxin and acipimox plasma concentrations and urinary excretion were measured after the first dose of acipimox and after a week of treatment 3 Data were fitted to a one-compartment oral absorption model. Areas under the plasma concentration-time curve, plasma and renal clearances, and elimination half-life were computed. 4 There was no significant difference in digoxin plasma concentrations and kinetic parameters before and after acipimox administration. Acipimox kinetics were not affected by the concomitant ingestion of digoxin. 5 The patients' clinical condition remained stable during the study. 6 Thus there was no evidence for an adverse interaction between digoxin and acipimox in human subjects under the conditions of this study.
引用
收藏
页码:357 / 359
页数:3
相关论文
共 50 条
  • [31] Lack of interaction between meloxicam and warfarin in healthy volunteers
    Turck, D
    Su, CAPF
    Heinzel, G
    Busch, U
    Bluhmki, E
    Hoffmann, J
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1997, 51 (05) : 421 - 425
  • [32] Lack of a clinically relevant interaction between etanercept (E) & digoxin (D).
    Patat, AA
    Parks, V
    Simcoe, DK
    Korth-Bradley, JM
    Le Coz, F
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2002, 71 (02) : P64 - P64
  • [33] LACK OF INTERACTION BETWEEN DIGOXIN AND QUINIDINE IN CULTURED HEART-CELLS
    HOROWITZ, JD
    BARRY, WH
    SMITH, TW
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1982, 220 (03): : 488 - 493
  • [34] LACK OF INTERACTION BETWEEN DIGOXIN AND QUINIDINE IN CULTURED HEART-CELLS
    HOROWITZ, JD
    BARRY, WH
    SMITH, TW
    CIRCULATION, 1981, 64 (04) : 96 - 96
  • [35] LACK OF INTERACTION BETWEEN DILTIAZEM AND DIGOXIN IN PATIENTS WITH HEART-DISEASE
    ELKAYAM, U
    PARIKH, K
    TORKAN, B
    WEBER, L
    COHEN, JL
    RAHIMTOOLA, SH
    CLINICAL RESEARCH, 1985, 33 (01): : A88 - A88
  • [36] Lack of effect of mizolastine on the safety and pharmacokinetics of digoxin administered orally in repeated doses to healthy volunteers
    Chaufour, S
    Le Coz, F
    Denolle, T
    Dubruc, C
    Cimarosti, I
    Deschamps, C
    Ulliac, N
    Delhotal-Landes, B
    Rosenzweig, P
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 1998, 36 (05) : 286 - 291
  • [37] Lack of effect of eprosartan on the single dose pharmacokinetics of orally administered digoxin in healthy male volunteers
    Martin, DE
    Tompson, D
    Boike, SC
    Tenero, D
    Ilson, B
    Citerone, D
    Jorkasky, DK
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1997, 43 (06) : 661 - 664
  • [38] Nateglinide, a New Mealtime Glucose RegulatorLack of Pharmacokinetic Interaction with Digoxin in Healthy Volunteers
    Honghui Zhou
    Yulia H. Walter
    Harold Smith
    Damayanthi Devineni
    James F. McLeod
    Clinical Drug Investigation, 2000, 19 : 465 - 471
  • [39] Lack of pharmacokinetic interaction between linezolid and antacid in healthy volunteers
    Grunder, G
    Zysset-Aschmann, Y
    Vollenweider, F
    Maier, T
    Krähenbühl, S
    Drewe, J
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2006, 50 (01) : 68 - 72
  • [40] Lack of pharmacokinetic interaction between lamotrigine and olanzapine in healthy volunteers
    Jann, MW
    Hon, YY
    Shamsi, SA
    Zheng, J
    Awad, EA
    Spratlin, V
    PHARMACOTHERAPY, 2006, 26 (05): : 627 - 633